Pacer Advisors
RVMD icon

Pacer Advisors’s Revolution Medicines RVMD Stock Holding History

Pacer Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60K Buy
+320
New +$46.7K ﹤0.01% 1993
2024
Q3 		– Sell
-1,056
Closed -$41K – 2676
2024
Q2 		$41K Sell
1,056
-270
-20% -$10.1K ﹤0.01% 3263
2024
Q1 		$42.7K Buy
+1,326
New +$39.3K ﹤0.01% 3232
2021
Q2 		– Sell
-1,630
Closed -$75K – 1537
2021
Q1 		$75K Sell
1,630
-642
-28% -$28.8K ﹤0.01% 1345
2020
Q4 		$90K Buy
+2,272
New +$89.8K ﹤0.01% 1377

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Pacer Advisors's RVMD Position: Q2 2026 in Review

Pacer Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 320 shares worth $60K. The stake represents ﹤0.01% of the portfolio and ranks #1993 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in RVMD as recently as Q2 2024.

Pacer Advisors first reported a position in RVMD in Q4 2020 and has held it in 5 quarters since. The position peaked at $90K in Q4 2020. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Pacer Advisors held 320 shares of Revolution Medicines worth $60K as of Q2 2026.
  • Revolution Medicines was a new Pacer Advisors position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1993 holding.
  • Pacer Advisors first reported a position in Revolution Medicines in Q4 2020 and has held it in 5 quarters since.
  • Pacer Advisors's Revolution Medicines position peaked at $90K in Q4 2020.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.